You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Heart failure

Chronic heart failure in adults: diagnosis and management

  • NICE guideline
  • Reference number: NG106
  • Published:  12 September 2018
  • Last updated:  03 September 2025
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Evidence

Documents containing the evidence that was used to develop the recommendations.

Supporting evidence

  • Economic analysis

  • Economic analysis report for chronic heart failure with reduced ejection fraction (PDF 920 KB)

    Published:
    03 September 2025
  • Other supporting evidence

  • Methods (PDF 490 KB)

    Published:
    03 September 2025
  • Evidence review

  • Evidence reviews - September 2025

  • A: Medicines for heart failure with reduced ejection fraction (PDF 6.41 MB)

    Published:
    03 September 2025
  • B: Medicines for heart failure with mildly reduced ejection fraction (PDF 3.07 MB)

    Published:
    03 September 2025
  • C: IV iron therapy for heart failure (PDF 3.16 MB)

    Published:
    03 September 2025
  • D: Mineralocorticoid receptor antagonist therapy for heart failure with preserved ejection fraction (PDF 2.04 MB)

    Published:
    03 September 2025
  • Surveillance report

  • 2023 exceptional surveillance of chronic heart failure in adults: diagnosis and management (NICE guideline NG106)

  • Appendix A: Equality and health inequalities assessment (PDF 175 KB)

    Published:
    25 April 2023
  • Full guidance

  • Full guideline (PDF 6.27 MB)

    Published:
    12 September 2018
  • Appendices A to S (PDF 8.81 MB)

    Published:
    12 September 2018
Back to top